Loading...
Loading...
Among the 3 tracked institutional investors we monitor, CTOR (CITIUS ONCOLOGY INC) is held with a combined value of $653.01K across 687,351 shares. The largest holder is VANGUARD GROUP INC with a position worth $597.00K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$653.01K
Total Shares Held
687,351
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $597.00K | 0.00% | New |
| 2 | BlackRock, Inc. | $29.42K | 0.00% | +112.4% |
| 3 | STATE STREET CORP | $26.59K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CTOR with a position worth $597.00K, representing 0.00% of their portfolio. In total, 3 institutional investors hold CTOR with a combined value of $653.01K.
In the most recent quarter, 1 fund opened a new position in CTOR. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $653.01K worth of CTOR stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $597.00K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CTOR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CTOR positions.